BrightSpring Health Services, Inc. (NASDAQ:BTSG) Receives Consensus Rating of “Moderate Buy” from Brokerages

BrightSpring Health Services, Inc. (NASDAQ:BTSGGet Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten research firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $21.67.

A number of brokerages recently weighed in on BTSG. Wells Fargo & Company boosted their price objective on shares of BrightSpring Health Services from $17.00 to $21.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Morgan Stanley boosted their price objective on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. Bank of America boosted their price objective on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. UBS Group boosted their price objective on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. Finally, CJS Securities assumed coverage on shares of BrightSpring Health Services in a report on Thursday, December 12th. They issued an “outperform” rating and a $27.00 price objective for the company.

View Our Latest Stock Analysis on BrightSpring Health Services

Institutional Investors Weigh In On BrightSpring Health Services

Hedge funds have recently modified their holdings of the business. L & S Advisors Inc bought a new stake in shares of BrightSpring Health Services during the 3rd quarter valued at $1,247,000. Virtu Financial LLC bought a new stake in shares of BrightSpring Health Services during the 3rd quarter valued at $522,000. Assenagon Asset Management S.A. bought a new stake in shares of BrightSpring Health Services during the 3rd quarter valued at $1,822,000. LMR Partners LLP bought a new stake in shares of BrightSpring Health Services during the 3rd quarter valued at $493,000. Finally, JPMorgan Chase & Co. grew its position in shares of BrightSpring Health Services by 275.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 163,618 shares of the company’s stock valued at $2,402,000 after acquiring an additional 120,005 shares during the period.

BrightSpring Health Services Stock Performance

Shares of BTSG opened at $18.39 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63. The business’s 50 day moving average price is $20.02 and its 200-day moving average price is $17.45. BrightSpring Health Services has a 52 week low of $7.85 and a 52 week high of $24.82. The stock has a market cap of $3.20 billion and a P/E ratio of -70.73.

BrightSpring Health Services Company Profile

(Get Free Report

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

Featured Articles

Analyst Recommendations for BrightSpring Health Services (NASDAQ:BTSG)

Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.